1. Home
  2. FXNC vs AKBA Comparison

FXNC vs AKBA Comparison

Compare FXNC & AKBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First National Corporation

FXNC

First National Corporation

HOLD

Current Price

$29.86

Market Cap

268.4M

Sector

Finance

ML Signal

HOLD

Logo Akebia Therapeutics Inc.

AKBA

Akebia Therapeutics Inc.

HOLD

Current Price

$0.55

Market Cap

248.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FXNC
AKBA
Founded
1907
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
268.4M
248.3M
IPO Year
2012
2014

Fundamental Metrics

Financial Performance
Metric
FXNC
AKBA
Price
$29.86
$0.55
Analyst Decision
Hold
Buy
Analyst Count
3
6
Target Price
★ $32.50
$3.92
AVG Volume (30 Days)
15.1K
★ 7.5M
Earning Date
11-06-2026
11-09-2026
Dividend Yield
★ 2.29%
N/A
EPS Growth
★ 96.00
93.94
EPS
★ 1.17
N/A
Revenue
★ $7,717,000.00
N/A
Revenue This Year
$5.70
N/A
Revenue Next Year
$4.38
N/A
P/E Ratio
$25.49
★ N/A
Revenue Growth
★ 7.40
N/A
52 Week Low
$22.09
$0.54
52 Week High
$33.24
$3.19

Technical Indicators

Market Signals
Indicator
FXNC
AKBA
Relative Strength Index (RSI) 48.39 18.58
Support Level $28.72 N/A
Resistance Level $30.41 $1.52
Average True Range (ATR) 0.63 0.05
MACD 0.05 -0.02
Stochastic Oscillator 58.39 2.43

Price Performance

Historical Comparison
FXNC
AKBA

About FXNC First National Corporation

First National Corp is a bank holding company of First Bank, which is a commercial bank. Its core offering includes loans, deposits, wealth management, and other products and services. The Company operates through two reportable operating segments: Community Banking and wealth management. The Community Banking segment involves making loans and generating deposits from individuals, businesses, and charitable organizations. Wealth Management Services offers corporate trustee services, trust and estate administration, IRA administration and custody services. The company has revenue from Community Banking segment.

About AKBA Akebia Therapeutics Inc.

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor approved in Japan for the treatment of anemia due to chronic kidney disease, and HIF-PH inhibitors in preclinical development.

Share on Social Networks: